Ts. Trovik et al., REDUCED SENSITIVITY TO BETA-ADRENOCEPTOR STIMULATION AND BLOCKADE IN INSULIN-DEPENDENT DIABETIC-PATIENTS WITH HYPOGLYCEMIA UNAWARENESS, British journal of clinical pharmacology, 38(5), 1994, pp. 427-432
1 Nine IDDM-patients with hypoglycaemia unawareness, seven IDDM-patien
ts withhypoglycemia awareness and a control group of nine healthy pers
ons were included in this study. The patients were recruited from the
medical out-patients' department of the University Hospital of Tromso.
2 The pathophysiological changes which cause hypoglycaemia unawarenes
s are today not clear. Reduced peripheral tissue sensitivity to catech
olamines is suggested as one of several mechanisms which may contribut
e. 3 For further investigation of beta-adrenergic sensitivity an isopr
enaline/metoprolol sensitivity test was performed. Isoprenaline and me
toprolol were administered intravenously, and the effects on heart rat
e (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP)
and plasma levels of adrenaline (ADR) and noradrenaline (NA) were meas
ured. All subjects were given the same doses of isoprenaline (0.25-8 m
u g) and metoprolol (0.5-8 mg). Metoprolol was given together with the
dose of isoprenaline which increased heart rate by 25 beats min(-1) 4
The dose/response curves of both isoprenaline/HR and metoprolol/HR we
re significantly shifted to the right in IDDM-patients with hypoglycae
mia unawareness compared with controls and IDDM-patients with hypoglyc
aemia awareness (P < 0.05). 5 Reduced sensitivity of isoprenaline stim
ulation has also been shown before, whereas reduced sensitivity of a b
locking agent has not earlier been shown. 6 These findings support the
hypothesis of reduced beta -adrenergic sensitivity as one pathophysio
logical component in hypoglycaemia unawareness. Nine IDDM-patients wit
h hypoglycaemia unawareness, seven IDDM-patients with